Global Brain Tumor Therapeutics Market 2019-2023
SKU ID :TNV-13494771 | Published Date: 13-May-2019 | No. of pages: 126Description
TOC
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
Market segmentation by type
Comparison by type
Small molecules - Market size and forecast 2018-2023
Biologics - Market size and forecast 2018-2023
Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Bristol-Myers Squibb Co.
Eisai Co. Ltd.
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Novartis AG
PART 15: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market characteristics analysis
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Global brain tumor therapeutics market pipeline: Overview
Exhibit 19: Global brain tumor therapeutics market pipeline: Snapshot
Exhibit 20: Type - Market share 2018-2023 (%)
Exhibit 21: Comparison by type
Exhibit 22: Small molecules - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Small molecules - Year-over-year growth 2019-2023 (%)
Exhibit 24: Biologics - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Biologics - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Customer landscape analysis
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: North America - Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in North America
Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Europe
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in Asia
Exhibit 40: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 42: Top 3 countries in ROW
Exhibit 43: Key leading countries
Exhibit 44: Market opportunity
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendor landscape analysis
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 53: Bristol-Myers Squibb Co. - Business segments
Exhibit 54: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 55: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 56: Bristol-Myers Squibb Co. - Key offerings
Exhibit 57: Bristol-Myers Squibb Co. - Key customers
Exhibit 58: Eisai Co. Ltd. - Vendor overview
Exhibit 59: Eisai Co. Ltd. - Business segments
Exhibit 60: Eisai Co. Ltd. - Organizational developments
Exhibit 61: Eisai Co. Ltd. - Geographic focus
Exhibit 62: Eisai Co. Ltd. - Segment focus
Exhibit 63: Eisai Co. Ltd. - Key offerings
Exhibit 64: Eisai Co. Ltd. - Key customers
Exhibit 65: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 66: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 67: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 68: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 69: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 70: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 71: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 72: Merck & Co. Inc. - Vendor overview
Exhibit 73: Merck & Co. Inc. - Business segments
Exhibit 74: Merck & Co. Inc. - Organizational developments
Exhibit 75: Merck & Co. Inc. - Geographic focus
Exhibit 76: Merck & Co. Inc. - Segment focus
Exhibit 77: Merck & Co. Inc. - Key offerings
Exhibit 78: Merck & Co. Inc. - Key customers
Exhibit 79: Novartis AG - Vendor overview
Exhibit 80: Novartis AG - Business segments
Exhibit 81: Novartis AG - Organizational developments
Exhibit 82: Novartis AG - Geographic focus
Exhibit 83: Novartis AG - Segment focus
Exhibit 84: Novartis AG - Key offerings
Exhibit 85: Novartis AG - Key customers
Exhibit 86: Validation techniques employed for market sizing
Exhibit 87: Definition of market positioning of vendors
Tables & Figures
Companies
Bristol-Myers Squibb Co.
Eisai Co. Ltd.
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Novartis AG
- PRICE
-
$2500$4000